Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Stevens

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|August 11, 2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative GroupsOdile Oberlin, Annie Rey, Kenneth L B Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2025
Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 StudyOdile Oberlin, Annie Rey, José Sanchez de Toledo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 studyOdile Oberlin, Annie Rey, José Sanchez de Toledo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groupsJ H M Merks, G L De Salvo, C Bergeron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89Michael C G Stevens, Annie Rey, Nathalie Bouvet, et al.
International Journal of Cancer|May 18, 2010
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors CommitteeDavid A Rodeberg, James R Anderson, Carola A Arndt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2016
Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experienceDaniel Orbach, Bernadette Brennan, Angela De Paoli, et al.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative GroupsDavid O Walterhouse, Donald A Barkauskas, David Hall, et al.
Cancer|December 7, 2017
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 studyBas Vaarwerk, Johanna H van der Lee, Willemijn B Breunis, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|August 11, 2015
Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative GroupsOdile Oberlin, Annie Rey, Kenneth L B Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2025
Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 StudyOdile Oberlin, Annie Rey, José Sanchez de Toledo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatric Oncology MMT95 studyOdile Oberlin, Annie Rey, José Sanchez de Toledo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groupsJ H M Merks, G L De Salvo, C Bergeron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2005
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89Michael C G Stevens, Annie Rey, Nathalie Bouvet, et al.
International Journal of Cancer|May 18, 2010
Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors CommitteeDavid A Rodeberg, James R Anderson, Carola A Arndt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2016
Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experienceDaniel Orbach, Bernadette Brennan, Angela De Paoli, et al.
Pediatric Blood & Cancer|May 22, 2018
Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groupsVeronique Minard-Colin, David Walterhouse, Gianni Bisogno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2018
Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative GroupsDavid O Walterhouse, Donald A Barkauskas, David Hall, et al.
Cancer|December 7, 2017
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 studyBas Vaarwerk, Johanna H van der Lee, Willemijn B Breunis, et al.
Pageof 6